The U.A.E. appears to have different policies on vaccine use in pregnancy and lactation federally and by emirate. The federal level policy presented below may not accurately reflect the emirate-specific policies. For example, the Dubai Health Authority has promoted vaccination in pregnancy since June 2021. For more information, please see the links below.
Based upon our document reviews, this timeline shows when each policy changed position, from most recent to oldest. The policy positions shown reflect the most permissive at that point in time, even if policies were more restrictive for specific vaccines.
Name (Click to sort ascending) | Pregnancy | Lactation |
|---|---|---|
| Emirate Medical Association |
| Name (Click to sort descending) | Administered (Click to sort ascending) | Pregnancy (Click to sort ascending) | Lactation (Click to sort ascending) | Other countries (Click to sort ascending) |
|---|---|---|---|---|
| Gamaleya Sputnik V | 54 | |||
| Moderna COVID-19 vaccine | 67 | |||
| Oxford-AstraZeneca Vaxzevria, Covishield | 187 | |||
| Pfizer/BioNTech Comirnaty | 127 | |||
| Sinopharm BIBP-CorV | 75 |
| Name (Click to sort descending) | Pregnancy (Click to sort ascending) | Lactation (Click to sort ascending) |
|---|---|---|
| Gamaleya Sputnik V | ||
| Moderna COVID-19 vaccine | ||
| Oxford-AstraZeneca Vaxzevria, Covishield | ||
| Pfizer/BioNTech Comirnaty | ||
| Sinopharm BIBP-CorV |
| Name (Click to sort descending) | Pregnancy (Click to sort ascending) | Lactation (Click to sort ascending) |
|---|---|---|
| Gamaleya Sputnik V | ||
| Pfizer/BioNTech Comirnaty | ||
| Sinopharm BIBP-CorV |